Deborah Weitzman, CEO of the PSS Segment at Cardinal Health (CAH), sold CAH shares on the open market once in the last year, totaling $3.2 million. Her most recent sale occurred on August 20, 2025. Among 11,678 individual insiders with open market sales, her activity ranks 2,598th by value, below the average of $8.6 million across about 6 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 1, 2025 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | F | Common Shares | 551 | $212.26 | 52,877.0000 | 239,000,000 | 1.03% | 0.00% |
| Aug. 20, 2025 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | S | Common Shares | 21367 | $150.53 | 53,428.0000 | 242,000,000 | 28.57% | 0.01% |
| Aug. 15, 2025 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | F | Common Shares | 24128 | $150.22 | 74,795.0000 | 242,000,000 | 24.39% | 0.01% |
| Aug. 15, 2025 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | A | Common Shares | 10694 | $0.00 | 98,923.0000 | 242,000,000 | 12.12% | 0.00% |
| Aug. 12, 2025 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | A | Common Shares | 39100 | $0.00 | 88,229.0000 | 242,000,000 | 79.59% | 0.02% |
| Dec. 2, 2024 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | F | Common Shares | 632 | $122.24 | 49,129.0000 | 245,000,000 | 1.27% | 0.00% |
| Aug. 15, 2024 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | A | Common Shares | 13530 | $0.00 | 52,102.0000 | 247,000,000 | 35.08% | 0.01% |
| Aug. 16, 2024 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | F | Common Shares | 2341 | $107.91 | 49,761.0000 | 247,000,000 | 4.49% | 0.00% |
| Aug. 15, 2024 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | F | Common Shares | 9918 | $106.36 | 38,572.0000 | 247,000,000 | 20.45% | 0.00% |
| Aug. 13, 2024 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, PSS Segment | A | Common Shares | 13926 | $0.00 | 48,490.0000 | 247,000,000 | 40.29% | 0.01% |
| Dec. 1, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | F | Common Shares | 638 | $107.08 | 34,564.0000 | 262,000,000 | 1.81% | 0.00% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Common Shares | 6279 | $83.19 | 56,471.0000 | 262,000,000 | 12.51% | 0.00% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Common Shares | 15373 | $66.43 | 71,844.0000 | 262,000,000 | 27.22% | 0.01% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | S | Common Shares | 36642 | $106.31 | 35,202.0000 | 262,000,000 | 51.00% | 0.01% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Employee Stock Option (right to buy) | 5990 | $0.00 | 0.0000 | 262,000,000 | 100.00% | 0.00% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Employee Stock Option (right to buy) | 6279 | $0.00 | 0.0000 | 262,000,000 | 100.00% | 0.00% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Employee Stock Option (right to buy) | 15373 | $0.00 | 0.0000 | 262,000,000 | 100.00% | 0.01% |
| Nov. 27, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Common Shares | 5990 | $84.27 | 50,192.0000 | 262,000,000 | 13.55% | 0.00% |
| Aug. 28, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | S | Common Shares | 6712 | $89.81 | 44,202.0000 | 262,000,000 | 13.18% | 0.00% |
| Aug. 28, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Employee Stock Option (right to buy) | 6712 | $0.00 | 0.0000 | 262,000,000 | 100.00% | 0.00% |
| Aug. 28, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M | Common Shares | 6712 | $71.43 | 50,914.0000 | 262,000,000 | 15.18% | 0.00% |
| Aug. 15, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | F | Common Shares | 10966 | $92.99 | 28,715.0000 | 262,000,000 | 27.64% | 0.00% |
| Aug. 16, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | A | Common Shares | 15487 | $0.00 | 44,202.0000 | 262,000,000 | 53.93% | 0.01% |
| Aug. 7, 2023 | CARDINAL HEALTH INC | $CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | A | Common Shares | 12760 | $0.00 | 39,681.0000 | 262,000,000 | 47.40% | 0.00% |